Skip to main content
Top
Published in: BMC Gastroenterology 1/2007

Open Access 01-12-2007 | Research article

Adherence to colorectal cancer screening guidelines in Canada

Authors: Maida J Sewitch, Caroline Fournier, Antonio Ciampi, Alina Dyachenko

Published in: BMC Gastroenterology | Issue 1/2007

Login to get access

Abstract

Background

To identify correlates of adherence to colorectal cancer (CRC) screening guidelines in average-risk Canadians.

Methods

2003 Canadian Community Health Survey Cycle 2.1 respondents who were at least 50 years old, without past or present CRC and living in Ontario, Newfoundland, Saskatchewan, and British Columbia were included. Outcomes, defined according to current CRC screening guidelines, included adherence to: i) fecal occult blood test (FOBT) (in prior 2 years), ii) endoscopy (colonoscopy/sigmoidoscopy) (prior 10 years), and iii) adherence to CRC screening guidelines, defined as either (i) or (ii). Generalized estimating equations regression was employed to identify correlates of the study outcomes.

Results

Of the 17,498 respondents, 70% were non-adherent CRC screening to guidelines. Specifically, 85% and 79% were non-adherent to FOBT and endoscopy, respectively. Correlates for all outcomes were: having a regular physician (OR = (i) 2.68; (ii) 1.91; (iii) 2.39), getting a flu shot (OR = (i) 1.59; (ii) 1.51; (iii) 1.55), and having a chronic condition (OR = (i) 1.32; (ii) 1.48; (iii) 1.43). Greater physical activity, higher consumption of fruits and vegetables and smoking cessation were each associated with at least 1 outcome. Self-perceived stress was modestly associated with increased odds of adherence to endoscopy and to CRC screening guidelines (OR = (ii) 1.07; (iii) 1.06, respectively).

Conclusion

Healthy lifestyle behaviors and factors that motivate people to seek health care were associated with adherence, implying that invitations for CRC screening should come from sources that are independent of physicians, such as the government, in order to reduce disparities in CRC screening.
Literature
3.
go back to reference Leddin D: The Canadian Association of Gastroenterology position on colon cancer screening. Can J Gastroenterol. 2003, 17: 133-134.CrossRefPubMed Leddin D: The Canadian Association of Gastroenterology position on colon cancer screening. Can J Gastroenterol. 2003, 17: 133-134.CrossRefPubMed
5.
go back to reference U.S. Preventive Services Task Force: Screening for colorectal cancer: recommendations and rationale. Ann Intern Med. 2002, 137: 129-131.CrossRef U.S. Preventive Services Task Force: Screening for colorectal cancer: recommendations and rationale. Ann Intern Med. 2002, 137: 129-131.CrossRef
6.
go back to reference Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, for the U.S.Multisociety Task Force on Colorectal Cancer: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003, 124: 544-560. 10.1053/gast.2003.50044.CrossRefPubMed Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S, Simmang C, for the U.S.Multisociety Task Force on Colorectal Cancer: Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003, 124: 544-560. 10.1053/gast.2003.50044.CrossRefPubMed
7.
go back to reference Rabeneck L, Paszat LF: A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol. 2004, 99: 1141-1144. 10.1111/j.1572-0241.2004.30623.x.CrossRefPubMed Rabeneck L, Paszat LF: A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol. 2004, 99: 1141-1144. 10.1111/j.1572-0241.2004.30623.x.CrossRefPubMed
8.
go back to reference Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S: Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detection and Prevention. 2005, 29: 221-226. 10.1016/j.cdp.2005.04.001.CrossRefPubMed Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S: Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detection and Prevention. 2005, 29: 221-226. 10.1016/j.cdp.2005.04.001.CrossRefPubMed
9.
go back to reference Hilsden RJ: Patterns of use of flexible sigmoidoscopy, colonoscopy and gastroscopy: a population-based study in a Canadian province. Can J Gastroenterol. 2004, 18: 213-2119.CrossRefPubMed Hilsden RJ: Patterns of use of flexible sigmoidoscopy, colonoscopy and gastroscopy: a population-based study in a Canadian province. Can J Gastroenterol. 2004, 18: 213-2119.CrossRefPubMed
10.
go back to reference Mack LA, Stuart H, Temple WJ: Survey of colorectal cancer screening practices in a large Canadian urban centre. Can J Surg. 2004, 47: 189-194.PubMedPubMedCentral Mack LA, Stuart H, Temple WJ: Survey of colorectal cancer screening practices in a large Canadian urban centre. Can J Surg. 2004, 47: 189-194.PubMedPubMedCentral
11.
go back to reference Hilsden RJ, McGregor SE, Murray A, Khoja S, Bryant H: Colorectal cancer screening: practices and attitudes of gastroenterologists, internists, and surgeons. Can J Surg. 2005, 48: 434-440.PubMedPubMedCentral Hilsden RJ, McGregor SE, Murray A, Khoja S, Bryant H: Colorectal cancer screening: practices and attitudes of gastroenterologists, internists, and surgeons. Can J Surg. 2005, 48: 434-440.PubMedPubMedCentral
12.
go back to reference Sewitch MJ, Burtin P, Dawes M, Yaffe M, Snell L, Roper M, Zanelli P, Pavilanis A: Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators. Can J Gastroenterol. 2006, 20: 713-718.CrossRefPubMedPubMedCentral Sewitch MJ, Burtin P, Dawes M, Yaffe M, Snell L, Roper M, Zanelli P, Pavilanis A: Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators. Can J Gastroenterol. 2006, 20: 713-718.CrossRefPubMedPubMedCentral
13.
14.
go back to reference McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA: The quality of health care delivered to adults in the United States. N Engl J Med. 2003, 348: 2635-2645. 10.1056/NEJMsa022615.CrossRefPubMed McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA: The quality of health care delivered to adults in the United States. N Engl J Med. 2003, 348: 2635-2645. 10.1056/NEJMsa022615.CrossRefPubMed
15.
go back to reference Etzioni DA, Ponce NA, Babey SH, Spencer BA, Brown ER, Ko CY, Chawla N, Breen N, Klabunde CN: A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004, 101: 2523-2532. 10.1002/cncr.20692.CrossRefPubMed Etzioni DA, Ponce NA, Babey SH, Spencer BA, Brown ER, Ko CY, Chawla N, Breen N, Klabunde CN: A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004, 101: 2523-2532. 10.1002/cncr.20692.CrossRefPubMed
16.
go back to reference Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D: Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiology, Biomarkers & Prevention. 2000, 9: 229-232. Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, Marcus A, Ahnen D: Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiology, Biomarkers & Prevention. 2000, 9: 229-232.
17.
go back to reference Madlensky L, McLaughlin J, Goel V: A comparison of self-reported colorectal screening with medical records. Cancer Epidemiology, Biomarkers & Prevention. 2003, 12: 656-659. Madlensky L, McLaughlin J, Goel V: A comparison of self-reported colorectal screening with medical records. Cancer Epidemiology, Biomarkers & Prevention. 2003, 12: 656-659.
19.
go back to reference Friedman LC, Webb JA, Richards S, Plon SE: Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Preventive Medicine. 1999, 29: 119-125. 10.1006/pmed.1999.0508.CrossRefPubMed Friedman LC, Webb JA, Richards S, Plon SE: Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Preventive Medicine. 1999, 29: 119-125. 10.1006/pmed.1999.0508.CrossRefPubMed
20.
go back to reference Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R: Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002, 23: 28-35. 10.1016/S0749-3797(02)00444-0.CrossRefPubMed Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R: Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002, 23: 28-35. 10.1016/S0749-3797(02)00444-0.CrossRefPubMed
21.
go back to reference Weitzman ER, Zapka J, Estabrook B, Goins KV: Risk and reluctance: understanding impediments to colorectal cancer screening. Preventive Medicine. 2001, 32: 502-513. 10.1006/pmed.2001.0838.CrossRefPubMed Weitzman ER, Zapka J, Estabrook B, Goins KV: Risk and reluctance: understanding impediments to colorectal cancer screening. Preventive Medicine. 2001, 32: 502-513. 10.1006/pmed.2001.0838.CrossRefPubMed
22.
go back to reference Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W, Babb J, Jandorf L: Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002, 21: 3-15. 10.1037/0278-6133.21.1.3.CrossRefPubMed Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W, Babb J, Jandorf L: Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002, 21: 3-15. 10.1037/0278-6133.21.1.3.CrossRefPubMed
23.
go back to reference Brawarsky P, Brooks DR, Mucci LA: Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med. 2003, 36: 659-668. 10.1016/S0091-7435(03)00046-X.CrossRefPubMed Brawarsky P, Brooks DR, Mucci LA: Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med. 2003, 36: 659-668. 10.1016/S0091-7435(03)00046-X.CrossRefPubMed
24.
go back to reference Brenes GA, Paskett ED: Predictors of stage of adoption for colorectal cancer screening. Preventive Medicine. 2000, 31: 410-416. 10.1006/pmed.2000.0729.CrossRefPubMed Brenes GA, Paskett ED: Predictors of stage of adoption for colorectal cancer screening. Preventive Medicine. 2000, 31: 410-416. 10.1006/pmed.2000.0729.CrossRefPubMed
25.
go back to reference Lemon S, Zapka J, Luckmann R, Chasan-Taber L: Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Pub Health. 2001, 91: 1264-1272.CrossRef Lemon S, Zapka J, Luckmann R, Chasan-Taber L: Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Pub Health. 2001, 91: 1264-1272.CrossRef
26.
go back to reference Nadel MR, Blackman DK, Shapiro JA, Seeff LC: Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Preventive Medicine. 2002, 35: 199-206. 10.1006/pmed.2002.1070.CrossRefPubMed Nadel MR, Blackman DK, Shapiro JA, Seeff LC: Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Preventive Medicine. 2002, 35: 199-206. 10.1006/pmed.2002.1070.CrossRefPubMed
27.
go back to reference Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L: Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ. 2004, 171: 461-465.CrossRefPubMedPubMedCentral Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L: Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ. 2004, 171: 461-465.CrossRefPubMedPubMedCentral
28.
go back to reference Kandula NR, Wen M, Jacobs EA, Lauderdale DS: Low rates of colorectal, cervical, and breast cancer screeningn in Asian Americans compared with non-hispanic whites. Cultural influences or access to care?. Cancer. 2006, 107: 184-192. 10.1002/cncr.21968.CrossRefPubMed Kandula NR, Wen M, Jacobs EA, Lauderdale DS: Low rates of colorectal, cervical, and breast cancer screeningn in Asian Americans compared with non-hispanic whites. Cultural influences or access to care?. Cancer. 2006, 107: 184-192. 10.1002/cncr.21968.CrossRefPubMed
29.
go back to reference Harewood GC, Wiersema MJ, Melton LJIII: A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol. 2002, 97: 3186-3194. 10.1111/j.1572-0241.2002.07129.x.CrossRefPubMed Harewood GC, Wiersema MJ, Melton LJIII: A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol. 2002, 97: 3186-3194. 10.1111/j.1572-0241.2002.07129.x.CrossRefPubMed
30.
go back to reference Walsh JME, Posner SF, Perez-Stable J: Colon cancer screening in the ambulatory setting. Prev Med. 2002, 35: 209-218. 10.1006/pmed.2002.1059.CrossRefPubMed Walsh JME, Posner SF, Perez-Stable J: Colon cancer screening in the ambulatory setting. Prev Med. 2002, 35: 209-218. 10.1006/pmed.2002.1059.CrossRefPubMed
31.
go back to reference Swan J, Breen N, Coates RJ, Rimer BK, Lee NC: Progress in cancer screening practices in the United States. Results from the 2000 National Health Interview Survey. Cancer. 2003, 97: 1528-1540. 10.1002/cncr.11208.CrossRefPubMed Swan J, Breen N, Coates RJ, Rimer BK, Lee NC: Progress in cancer screening practices in the United States. Results from the 2000 National Health Interview Survey. Cancer. 2003, 97: 1528-1540. 10.1002/cncr.11208.CrossRefPubMed
32.
go back to reference Brouse CH, Basch CE, Wolf RL, Shmukler C, Neugut AI, Shea S: Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Pub Health. 2003, 93: 1268-1271.CrossRef Brouse CH, Basch CE, Wolf RL, Shmukler C, Neugut AI, Shea S: Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Pub Health. 2003, 93: 1268-1271.CrossRef
33.
go back to reference Shapiro JA, Seeff LC, Nadel MR: Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med. 2002, 21: 132-137. 10.1016/S0749-3797(01)00329-4.CrossRef Shapiro JA, Seeff LC, Nadel MR: Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med. 2002, 21: 132-137. 10.1016/S0749-3797(01)00329-4.CrossRef
36.
go back to reference Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika. 1986, 73: 13-22. 10.1093/biomet/73.1.13.CrossRef Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika. 1986, 73: 13-22. 10.1093/biomet/73.1.13.CrossRef
37.
go back to reference SAS Institute Inc: The GENMOD procedure. SAS/STAT Software: Changes and Enhancements for Release 6.12. 1996, Cary, NC, USA, SAS Institute, Inc., 23-42. SAS Institute Inc: The GENMOD procedure. SAS/STAT Software: Changes and Enhancements for Release 6.12. 1996, Cary, NC, USA, SAS Institute, Inc., 23-42.
39.
go back to reference Thompson B, Coronado GD, Solomon CC, McClerran DF, Neuhouser ML, Feng Z: Cancer prevention behaviours and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes and Control. 2002, 13: 719-728. 10.1023/A:1020280427712.CrossRefPubMed Thompson B, Coronado GD, Solomon CC, McClerran DF, Neuhouser ML, Feng Z: Cancer prevention behaviours and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States. Cancer Causes and Control. 2002, 13: 719-728. 10.1023/A:1020280427712.CrossRefPubMed
40.
go back to reference Ioannou GN, Chapko MK, Dominitz JA: Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003, 98: 2082-2091. 10.1111/j.1572-0241.2003.07574.x.CrossRefPubMed Ioannou GN, Chapko MK, Dominitz JA: Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003, 98: 2082-2091. 10.1111/j.1572-0241.2003.07574.x.CrossRefPubMed
41.
go back to reference Harewood GC, Lieberman DA: Colonoscopy practice patterns since introduction of Medicare coverage for average-risk screening. Clin Gastroenterol Hepatol. 2004, 2: 72-77. 10.1016/S1542-3565(03)00294-5.CrossRefPubMed Harewood GC, Lieberman DA: Colonoscopy practice patterns since introduction of Medicare coverage for average-risk screening. Clin Gastroenterol Hepatol. 2004, 2: 72-77. 10.1016/S1542-3565(03)00294-5.CrossRefPubMed
42.
go back to reference Whynes DK, Frew EJ, Manghan CM, Scholefield JH, Hardcastle JD: Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Pub Health. 2003, 117: 389-395. 10.1016/S0033-3506(03)00146-X.CrossRef Whynes DK, Frew EJ, Manghan CM, Scholefield JH, Hardcastle JD: Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Pub Health. 2003, 117: 389-395. 10.1016/S0033-3506(03)00146-X.CrossRef
43.
go back to reference McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A: Low uptake of colorectal cancer screening 4 yr after release of national recommendations for screenig. Am J Gastroenterol. 2007, 102: 1-9. 10.1111/j.1572-0241.2007.01217.x.CrossRef McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A: Low uptake of colorectal cancer screening 4 yr after release of national recommendations for screenig. Am J Gastroenterol. 2007, 102: 1-9. 10.1111/j.1572-0241.2007.01217.x.CrossRef
44.
go back to reference Wardle J, Miles A, Atkin W: Gender differences in utilization of colorectal cancer screening. J Med Screen. 2005, 12: 20-27. 10.1258/0969141053279158.CrossRefPubMed Wardle J, Miles A, Atkin W: Gender differences in utilization of colorectal cancer screening. J Med Screen. 2005, 12: 20-27. 10.1258/0969141053279158.CrossRefPubMed
45.
go back to reference Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ: Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004, 100: 2093-2103. 10.1002/cncr.20276.CrossRefPubMed Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ: Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004, 100: 2093-2103. 10.1002/cncr.20276.CrossRefPubMed
46.
go back to reference Ko CW, Kreuter W, Baldwin LM: Persistent demographic differences incolorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol. 2005, 5: 10-10.1186/1471-230X-5-10.CrossRefPubMedPubMedCentral Ko CW, Kreuter W, Baldwin LM: Persistent demographic differences incolorectal cancer screening utilization despite Medicare reimbursement. BMC Gastroenterol. 2005, 5: 10-10.1186/1471-230X-5-10.CrossRefPubMedPubMedCentral
47.
go back to reference Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ: Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Preventive Medicine. 2003, 36: 85-91. 10.1006/pmed.2002.1127.CrossRefPubMed Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ: Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Preventive Medicine. 2003, 36: 85-91. 10.1006/pmed.2002.1127.CrossRefPubMed
48.
go back to reference Cooper GS, Koroukian SM: Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2003, 100: 418-424. 10.1002/cncr.20014.CrossRef Cooper GS, Koroukian SM: Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2003, 100: 418-424. 10.1002/cncr.20014.CrossRef
49.
go back to reference Rao RS, Graubard BI, Breen N, Gastwirth JL: Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care. 2004, 42: 789-800. 10.1097/01.mlr.0000132838.29236.7e.CrossRefPubMed Rao RS, Graubard BI, Breen N, Gastwirth JL: Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care. 2004, 42: 789-800. 10.1097/01.mlr.0000132838.29236.7e.CrossRefPubMed
50.
go back to reference Cooper GS, Koroukian SM: Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol. 2004, 99: 1544-1550. 10.1111/j.1572-0241.2004.30902.x.CrossRefPubMed Cooper GS, Koroukian SM: Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol. 2004, 99: 1544-1550. 10.1111/j.1572-0241.2004.30902.x.CrossRefPubMed
54.
go back to reference Walter LC, Covinsky KE: Cancer screening in elderly patients. a framework for individualized decision making. JAMA. 2006, 285: 2750-2756. 10.1001/jama.285.21.2750.CrossRef Walter LC, Covinsky KE: Cancer screening in elderly patients. a framework for individualized decision making. JAMA. 2006, 285: 2750-2756. 10.1001/jama.285.21.2750.CrossRef
Metadata
Title
Adherence to colorectal cancer screening guidelines in Canada
Authors
Maida J Sewitch
Caroline Fournier
Antonio Ciampi
Alina Dyachenko
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2007
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-7-39

Other articles of this Issue 1/2007

BMC Gastroenterology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.